day trading jan 3 - all day, page-6

  1. 30,236 Posts.
    lightbulb Created with Sketch. 206
    Admedus (ASX: AHZ) today announced the transaction to acquire an established manufacturing site from Genzyme Australia to facilitate scaled-up production of its lead regenerative tissue product CardioCel® has now been completed. The transaction was completed on the 31st of December, 2013 in accordance to the share purchase agreement.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.